Director's Dealings/Grant of option17 Nov 2017 14:36
Fri, 17th Nov 2017 14:24
RNS Number : 8699W
Proxama PLC
17 November 2017
17 November 2017
Proxama PLC
("Proxama" or the "Company")
Director's Dealings and Grant of Options
Director's Dealings
Proxama PLC, (AIM: PROX), the leading mobile location and data intelligence expert, announces that its Chief Executive Officer, Mark Slade, purchased 76,000,000 ordinary shares of 0.01p in the Company ("Ordinary Shares") at a price of 0.0265p per share on 16 November 2017. Following this purchase, Mark Slade now holds a total of 176,000,000 ordinary shares in the company representing 1.28% of the current issued share capital of the Company.
Grant of Options
On 14 November 2017, options over Ordinary Shares were granted to three directors with an exercise price of 0.03p as detailed below. These are exercisable, subject to performance criteria, after three years and within ten years of grant.
Mark Slade: 549,829,880
Dan Francis: 175,708,610
Kelvin Harrison: 66,666,667
Mark Slade has been granted an additional 687,287,350 options over the Company's Ordinary Shares, with an exercise price of 0.03p and subject to separate performance criteria, which are also exercisable after three years and within ten years of grant.
The Company has a total of 13,745,747,069 Ordinary Shares in issue with options granted over a further 1,562,740,546 Ordinary Shares. In addition Darwin holds 558,352,249 warrants at an exercise price of 0.1692 pence per share and Barclays holds 5,863,021,931 warrants at an exercise price of 0.03 pence per share.
Sign In
Follow the stocks
